Triplebar
PrivateLast Round
Series B
Dec 12, 2024
Total Funding Raised
$26M
Company Overview
Triplebar is a biotechnology company that operates a hyper-throughput screening platform to develop products for the food and biopharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Sustainable Materials, ML Platforms
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triplebar Comps
Public and private peers based on sector, stage, and business model.
Triplebar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 12, 2024 | ||||
| Series A | Oct 30, 2023 |
Triplebar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Production Board | Series A, Seed |
| iSelect Fund | Series A |
| Synthesis Capital | Series A |
| Essential Capital | Series A |
| Stray Dog Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 20, 2025
Shawn Manchester appointed as the new Chief Executive Officer.
Triplebar Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triplebar's valuation, stock price, and market status.
